{"id":{"repo_id":"usf","oai_identifier":"oai:digitalcommons.usf.edu:etd-11625"},"canonical_url":"https://search.ndltd.org/etd/usf/oai:digitalcommons.usf.edu:etd-11625","repository":{"repo_id":"usf","name":"University of South Florida","base_url":"https://digitalcommons.usf.edu/do/oai/"},"display":{"title":"Antimicrobial Activity of Zinc Oxide Nanoparticles Compared to Silver Nanoparticles Administered towards Methicillin-Resistant <em>Staphylococcus</em> aureus Biofilms","abstract":"Zinc oxide nanoparticles (ZnO NPs), silver nanoparticles (AgNPs), and chitosan nanoparticles have strong antibacterial activity as a broad-spectrum antibiotic against multi-drug resistant (MDR) bacteria. MDR bacteria have a mechanism that increases antibiotic resistance through biofilm formations. MDR methicillin-resistant Staphylococcus aureus BAA-1720 was chosen for an in vitro assessment to calculate the biofilm reduction rate and the median effective dose (ED50) by performing biofilm quantification. Dynamic light scattering was chosen to determine the physiochemical characteristics of ZnO NPs, silver nanoparticles (AgNPs), and chitosan NPs. Transmission electron microscopy was conducted to verify each treatment’s physiochemical characteristics. Antimicrobial susceptibility testing of broad-spectrum and Gram-positive antibiotics was coordinated for MRSA and revealed a total of 17 resistant antibiotics, with 2 additional ones assumed from performed tests. Biofilm quantification revealed the average biofilm reduction rate for 26.7 µg/mL AgNPs at 177.0% after 24 hours (ED50 = 7.54 µg/mL), when compared to 150 µg/mL ZnO NPs (75.97%, ED50 = 98.72 µg/mL) and 150 µg/mL chitosan NPs (6.53%, ED50 = 1149 µg/mL). Based on previous experiments, it is unlikely that chitosan would have such a low biofilm reduction potential and such a high ED 50; however, this value could be due to an experimental error. Confocal microscopy reflected the antibacterial activity of AgNPs. Despite AgNPs exhibiting a higher biofilm reduction rate and lower ED50 than ZnO NPs, both metallic NPs show promise in treating MDR bacterial biofilms.","abstract_html":"Zinc oxide nanoparticles (ZnO NPs), silver nanoparticles (AgNPs), and chitosan nanoparticles have strong antibacterial activity as a broad-spectrum antibiotic against multi-drug resistant (MDR) bacteria. MDR bacteria have a mechanism that increases antibiotic resistance through biofilm formations. MDR methicillin-resistant Staphylococcus aureus BAA-1720 was chosen for an in vitro assessment to calculate the biofilm reduction rate and the median effective dose (ED50) by performing biofilm quantification. Dynamic light scattering was chosen to determine the physiochemical characteristics of ZnO NPs, silver nanoparticles (AgNPs), and chitosan NPs. Transmission electron microscopy was conducted to verify each treatment’s physiochemical characteristics. Antimicrobial susceptibility testing of broad-spectrum and Gram-positive antibiotics was coordinated for MRSA and revealed a total of 17 resistant antibiotics, with 2 additional ones assumed from performed tests. Biofilm quantification revealed the average biofilm reduction rate for 26.7 µg/mL AgNPs at 177.0% after 24 hours (ED50 = 7.54 µg/mL), when compared to 150 µg/mL ZnO NPs (75.97%, ED50 = 98.72 µg/mL) and 150 µg/mL chitosan NPs (6.53%, ED50 = 1149 µg/mL). Based on previous experiments, it is unlikely that chitosan would have such a low biofilm reduction potential and such a high ED 50; however, this value could be due to an experimental error. Confocal microscopy reflected the antibacterial activity of AgNPs. Despite AgNPs exhibiting a higher biofilm reduction rate and lower ED50 than ZnO NPs, both metallic NPs show promise in treating MDR bacterial biofilms.","abstract_has_math":false,"creators":["Núño, Kevin"],"institution":"University of South Florida","degree_name":"Master of Science (M.S.)","degree_level":"Thesis","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":["Alya Limayem, Ph.D.","Mark Kindy, Ph.D.","Feng Cheng, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2022,"date_issued":"2022-03-18T07:00:00Z","date_published":"2022-03-18T07:00:00Z","updated_at":"2026-11-19T08:48:59Z","subjects":["TEM","confocal microscopy","antimicrobial susceptibity","biofilm quantification","MRSA","multi-drug resistance","nanomedicine","Medicinal Chemistry and Pharmaceutics","Microbiology","Nanoscience and Nanotechnology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usf.edu/etd/10338","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usf.edu/etd/10338","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usf.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usf.edu%3Aetd-11625","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Alya Limayem, Ph.D.","Mark Kindy, Ph.D.","Feng Cheng, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Núño, Kevin"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2022-03-18T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis","M.S."]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (M.S.)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of South Florida"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["TEM","confocal microscopy","antimicrobial susceptibity","biofilm quantification","MRSA","multi-drug resistance","nanomedicine","Medicinal Chemistry and Pharmaceutics","Microbiology","Nanoscience and Nanotechnology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights.license","label":"Dc Rights License","values":["default"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usf.edu/etd/10338"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Zinc oxide nanoparticles (ZnO NPs), silver nanoparticles (AgNPs), and chitosan nanoparticles have strong antibacterial activity as a broad-spectrum antibiotic against multi-drug resistant (MDR) bacteria. MDR bacteria have a mechanism that increases antibiotic resistance through biofilm formations. MDR methicillin-resistant Staphylococcus aureus BAA-1720 was chosen for an in vitro assessment to calculate the biofilm reduction rate and the median effective dose (ED50) by performing biofilm quantification. Dynamic light scattering was chosen to determine the physiochemical characteristics of ZnO NPs, silver nanoparticles (AgNPs), and chitosan NPs. Transmission electron microscopy was conducted to verify each treatment’s physiochemical characteristics. Antimicrobial susceptibility testing of broad-spectrum and Gram-positive antibiotics was coordinated for MRSA and revealed a total of 17 resistant antibiotics, with 2 additional ones assumed from performed tests. Biofilm quantification revealed the average biofilm reduction rate for 26.7 µg/mL AgNPs at 177.0% after 24 hours (ED50 = 7.54 µg/mL), when compared to 150 µg/mL ZnO NPs (75.97%, ED50 = 98.72 µg/mL) and 150 µg/mL chitosan NPs (6.53%, ED50 = 1149 µg/mL). Based on previous experiments, it is unlikely that chitosan would have such a low biofilm reduction potential and such a high ED 50; however, this value could be due to an experimental error. Confocal microscopy reflected the antibacterial activity of AgNPs. Despite AgNPs exhibiting a higher biofilm reduction rate and lower ED50 than ZnO NPs, both metallic NPs show promise in treating MDR bacterial biofilms."]},{"key":"dc:title","label":"Title","values":["Antimicrobial Activity of Zinc Oxide Nanoparticles Compared to Silver Nanoparticles Administered towards Methicillin-Resistant <em>Staphylococcus</em> aureus Biofilms"]}]}],"canonical_facts":{"dc:contributor":["Alya Limayem, Ph.D.","Mark Kindy, Ph.D.","Feng Cheng, Ph.D."],"dc:creator":["Núño, Kevin"],"dc:date":["2022-03-18T07:00:00Z"],"dc:description":["Zinc oxide nanoparticles (ZnO NPs), silver nanoparticles (AgNPs), and chitosan nanoparticles have strong antibacterial activity as a broad-spectrum antibiotic against multi-drug resistant (MDR) bacteria. MDR bacteria have a mechanism that increases antibiotic resistance through biofilm formations. MDR methicillin-resistant Staphylococcus aureus BAA-1720 was chosen for an in vitro assessment to calculate the biofilm reduction rate and the median effective dose (ED50) by performing biofilm quantification. Dynamic light scattering was chosen to determine the physiochemical characteristics of ZnO NPs, silver nanoparticles (AgNPs), and chitosan NPs. Transmission electron microscopy was conducted to verify each treatment’s physiochemical characteristics. Antimicrobial susceptibility testing of broad-spectrum and Gram-positive antibiotics was coordinated for MRSA and revealed a total of 17 resistant antibiotics, with 2 additional ones assumed from performed tests. Biofilm quantification revealed the average biofilm reduction rate for 26.7 µg/mL AgNPs at 177.0% after 24 hours (ED50 = 7.54 µg/mL), when compared to 150 µg/mL ZnO NPs (75.97%, ED50 = 98.72 µg/mL) and 150 µg/mL chitosan NPs (6.53%, ED50 = 1149 µg/mL). Based on previous experiments, it is unlikely that chitosan would have such a low biofilm reduction potential and such a high ED 50; however, this value could be due to an experimental error. Confocal microscopy reflected the antibacterial activity of AgNPs. Despite AgNPs exhibiting a higher biofilm reduction rate and lower ED50 than ZnO NPs, both metallic NPs show promise in treating MDR bacterial biofilms."],"dc:identifier":["https://digitalcommons.usf.edu/etd/10338"],"dc:rights.license":["default"],"dc:subject":["TEM","confocal microscopy","antimicrobial susceptibity","biofilm quantification","MRSA","multi-drug resistance","nanomedicine","Medicinal Chemistry and Pharmaceutics","Microbiology","Nanoscience and Nanotechnology"],"dc:title":["Antimicrobial Activity of Zinc Oxide Nanoparticles Compared to Silver Nanoparticles Administered towards Methicillin-Resistant <em>Staphylococcus</em> aureus Biofilms"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["Thesis","M.S."],"thesis:degree_name":["Master of Science (M.S.)"],"thesis:institution_name":["University of South Florida"]},"updated_at":"2026-11-19T08:48:59Z"}